Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2017 - Production, Sales, Supply, Demand, Analysis & Forecast to 2022

Download as PDF 

 Published: May-2017 |  Format: PDF | QY Research |  Number of pages: 126 |

Description
Summary

This report studies the Non-steroidal Anti-inflammatory Drugs (NSAID) market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Non-steroidal Anti-inflammatory Drugs (NSAID) market by product type and applications/end industries.

The global Non-steroidal Anti-inflammatory Drugs (NSAID) market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

USA, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-steroidal Anti-inflammatory Drugs (NSAID).

Europe also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.

The major players in global Non-steroidal Anti-inflammatory Drugs (NSAID) market include Bayer (DE), Novacap (FR), Abbott, Pfizer Inc, Geri-Care Pharmaceuticals, Perrigo Company, Kopran Ltd., Merck Sharp & Dohme Corp., Sun Pharmaceutical Industries Ltd, GlaxoSmithKline, 
Reddy Pharmaceuticals Ltd, Johnson & Johnson

Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of Non-steroidal Anti-inflammatory Drugs (NSAID) in these regions, from 2012 to 2022 (forecast), covering
USA
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Non-steroidal Anti-inflammatory Drugs (NSAID) market is primarily split into 
Salicylates
Propionic acid derivatives 
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Others

On the basis on the end users/applications, this report covers 
Back pain treatment
Osteoarthritis treatment
Other disease treatment
Table of Content

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report 2017
1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Overview
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Types (Product Category)
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth (%) Comparison by Types (2012-2022)
1.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Types in 2016
1.2.3 Salicylates
1.2.4 Propionic acid derivatives
1.2.5 Acetic acid derivatives
1.2.6 Enolic acid (Oxicam) derivatives
1.2.7 Anthranilic acid derivatives (Fenamates)
1.2.8 Selective COX-2 inhibitors (Coxibs)
1.2.9 Sulfonanilides
1.2.10 Others
1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Applications
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) Comparison by Applications (2012-2022)
1.3.2 Back pain treatment
1.3.3 Osteoarthritis treatment
1.3.4 Other disease treatment
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Regions (2012-2022)
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth (%) Comparison by Regions (2012-2022)
1.4.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2012-2022)
1.4.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2012-2022)
1.4.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2012-2022)
1.4.5 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2012-2022)
1.4.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Status and Prospect (2012-2022)
1.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (2012-2022)
1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Status and Outlook (2012-2022)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) Status and Outlook (2012-2022)

2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers/Brand
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Share by Manufacturers (2012-2017)
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Share by Manufacturers (2012-2017)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Pcs) by Manufacturers (2012-2017)
2.4 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution, Sales Area, Product Types
2.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends
2.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate
2.5.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD) by Regions (2012-2017)
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Market Share (%) by Regions (2012-2017)
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.5 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.6 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.7 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.8 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
3.9 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)

4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price Trend by Types
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Market Share (%) by Types (2012-2017)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share (%) by Types (2012-2017)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Pcs) by Type (2012-2017)
4.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth by Type (2012-2017)

5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis by Applications
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Market Share (%) by Applications (2012-2017)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) by Applications (2012-2017)

6 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Profiles/Analysis
6.1 Bayer (DE)
6.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novacap (FR)
6.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Abbott
6.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer Inc
6.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.4.2.1 Product A
6.4.2.2 Product A
6.4.3 Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Geri-Care Pharmaceuticals
6.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.5.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Perrigo Company
6.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Kopran Ltd.
6.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.7.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Merck Sharp & Dohme Corp.
6.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sun Pharmaceutical Industries Ltd
6.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.9.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
6.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category, End Uses and Specification
6.10.2.1 Type A
6.10.2.2 Type B
6.10.3 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Reddy Pharmaceuticals Ltd
6.12 Johnson & Johnson
6.13 …

7 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast (2017-2022)
11.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
11.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
11.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price and Trend Forecast (2017-2022)
11.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Forecast by Regions (2017-2022)
11.2.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.4 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.5 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) Forecast by Type (2017-2022)
11.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Tables and Figures 

Figure Global Market Size (Million USD) Status and Outlook 2012-2022
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Market Split by Regions
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Figure Product Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Types in 2016
Figure Product Picture of Salicylates
Table Major Manufacturers of Salicylates
Figure Product Picture of Propionic acid derivatives
Table Major Manufacturers of Propionic acid derivatives
Figure Product Picture of Acetic acid derivatives
Table Major Manufacturers of Acetic acid derivatives
Figure Product Picture of Enolic acid (Oxicam) derivatives
Table Major Manufacturers of Enolic acid (Oxicam) derivatives
Figure Product Picture of Anthranilic acid derivatives (Fenamates)
Table Major Manufacturers of Anthranilic acid derivatives (Fenamates)
Figure Product Picture of Selective COX-2 inhibitors (Coxibs)
Table Major Manufacturers of Selective COX-2 inhibitors (Coxibs)
Figure Product Picture of Sulfonanilides
Table Major Manufacturers of Sulfonanilides
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) Comparison by Applications (2012-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Applications in 2016
Figure Back pain treatment Examples
Table Key Downstream Customer in Back pain treatment
Figure Osteoarthritis treatment Examples
Table Key Downstream Customer in Other disease treatment
Figure Other disease treatment Examples
Table Key Downstream Customer in Other disease treatment
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Comparison and Growth (%) by Regions (2012-2022)
Table Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Comparison by Regions 2012-2022
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) Status and Outlook (2012-2022)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) of Key Manufacturers (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share (%) by Manufacturers (2012-2017)
Figure 2016 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share (%) by Manufacturers
Figure 2017Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share (%) by Manufacturers
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share (%) by Manufacturers (2012-2017)
Table 2016 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share (%) by Manufacturers
Table 2016 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share (%) by Manufacturers
Table Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Category
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) of Top 3 Manufacturers
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) of Top 5 Manufacturers
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) by Regions (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Regions (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Regions (2012-2017)
Figure 2016 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Regions
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) by Regions (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) by Regions (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) by Regions
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) by Types (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share (%) by Types (2012-2017)
Figure Sales Market Share (%) of Non-steroidal Anti-inflammatory Drugs (NSAID) by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Non-steroidal Anti-inflammatory Drugs (NSAID) by Types
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) by Types (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share (%) by Types (2012-2017)
Figure Revenue Share (%) of Non-steroidal Anti-inflammatory Drugs (NSAID) by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Non-steroidal Anti-inflammatory Drugs (NSAID) by Types
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Pcs) by Types (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth (%) by Type (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) by Applications (2012-2017)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Applications (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Applications (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) by Applications in 2016
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) by Applications (2012-2017)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) by Applications (2012-2017)
Table Bayer (DE) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Novacap (FR) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Pfizer Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Geri-Care Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Perrigo Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Kopran Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Merck Sharp & Dohme Corp. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (%) (2012-2017)
Figure GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) (2012-2017)
Figure GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
Table Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2016
Table Major Buyers of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Distributors/Traders List
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price and Trend Forecast (2017-2022)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) Forecast by Regions (2017-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) Forecast by Regions (2017-2022)
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (%) Forecast (2017-2022)
Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (Million USD) Forecast by Type (2017-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share (%) Forecast by Type (2017-2022)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share (%) Forecast by Type (2017-2022)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



Latest News

21-Nov-2017 | Others

Price Crash in International Market Reduced Margins in Dairy Sector

The profit margins of Indian dairy companies have fallen sharply. For the past few months, skimmed milk powder (SMP) prices have fallen in the international market. Apart from this, the GST in the domestic market has doubled the tax on GST compared to the earlier rates. Due to this, dairy companies have reduced procurement prices from 10% to 22% for the last few months. Prakash Kutwal, secretar ...

21-Nov-2017 | Agriculture

Rising Implementation of Automation to Burgeon the Agricultural Robots Market

Technological progression has had a wide-ranging influence on a variety of industries such as food & beverage, packaging, agriculture, construction, and healthcare. With the constant demographic rush, the food demand is rapidly mounting by the customers. This has resulted in the gradual implementation of technological solutions to propel the agricultural output by the agricultural industry. ...

15-Nov-2017 | IT & Telecommunications

Inclusion of Cortana to Skype Will Boost the Global Artificial Intelligence Market

The US-located tech major Microsoft has declared that Cortana, its virtual assistant, will now be accessible on Skype, its video communication tool. This decision of the company is sure to boost the global artificial intelligence market. As per official blog post of Microsoft, this feature will be obtainable starting this week for both Android and iOS consumers in the U.S., but as of now there ...

15-Nov-2017 | Consumer Goods & Retailing

Increasing Demand for Carbon Black to Boost Its Market

Carbon black is a deep black-colored, fine powder that is produced by burning hydrocarbons in inadequate air. Owing to its conducting, tinting, and reinforcing properties, it is used in numerous sectors. The largest consumer of carbon black is the tire industry. It elevates the abrasion resistance and tensile strength of the automotive tires and offers strength and longevity. There has been a s ...

06-Nov-2017 | Medical Devices

Low Tolerance toward Pest Nuisance to Boost the Home Insecticide Market

Insecticides are acknowledged to be extensively utilized to deter, kill, or control insects in the agriculture and correlated field action. These insect-demolishing agents can be organic and synthetic as well in nature or a mixture of both. However, the rising demand to wipe out the presence of insect in households has resulted in a positive growth of the home insecticide market. Several insect ...